RxDoctor Payments DataLook up a doctor →

Laila Agrawal, MD

Hematology & Oncology · Louisville, KYNPI 1366670234

Payments from drug & device makers

$6,325,149in general payments, 2019–2025

Across 473 payments — averaging $13,372 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2.1M
  • Seagen Inc.$1.8M
  • AstraZeneca$823K
  • Novartis$728K
  • Daiichi Sankyo Inc.$495K
  • Astrazeneca UK Limited$166K
  • plus $181K from 12 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,325,149 in reported general payments places this provider in the 95th percentile of 143 hematology & oncology providers in Kentucky.

See all hematology & oncology providers in Kentucky

Medicare billing

Part B allowed, 2024
$77,822
Medicare patients
315
Services billed
952

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →